J.R. Selden

961 total citations
25 papers, 804 citations indexed

About

J.R. Selden is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, J.R. Selden has authored 25 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Hematology. Recurrent topics in J.R. Selden's work include Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Molecular Biology Techniques and Applications (3 papers). J.R. Selden is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Molecular Biology Techniques and Applications (3 papers). J.R. Selden collaborates with scholars based in United States, Australia and Italy. J.R. Selden's co-authors include Peter C. Nowell̀, Carlo M. Croce, Donald F. Patterson, Beverly S. Emanuel, Frank Dolbeare, G Rovera, J Finan, Paul S. Moorhead, Mark E. Haskins and Stephen S. Wachtel and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

J.R. Selden

25 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.R. Selden United States 15 469 258 129 96 87 25 804
B. Kaiser McCaw United States 8 334 0.7× 198 0.8× 110 0.9× 103 1.1× 121 1.4× 18 775
J A Lautenberger United States 11 789 1.7× 256 1.0× 126 1.0× 80 0.8× 204 2.3× 17 1.2k
Kavita S. Reddy United States 19 254 0.5× 380 1.5× 132 1.0× 224 2.3× 54 0.6× 55 846
K.‐O. Söderström Finland 18 355 0.8× 193 0.7× 59 0.5× 36 0.4× 95 1.1× 49 878
Gregory B. Peters Australia 21 773 1.6× 420 1.6× 83 0.6× 61 0.6× 247 2.8× 33 1.3k
H.L. Drwinga United States 6 340 0.7× 148 0.6× 69 0.5× 86 0.9× 141 1.6× 10 598
AD Auerbach United States 9 730 1.6× 244 0.9× 328 2.5× 67 0.7× 174 2.0× 10 1.0k
Alan J. Kinniburgh United States 23 1.3k 2.8× 173 0.7× 177 1.4× 206 2.1× 156 1.8× 45 1.7k
Jochen Bruch Germany 16 378 0.8× 316 1.2× 111 0.9× 34 0.4× 139 1.6× 28 825
Isabelle Lamrissi‐Garcia France 14 661 1.4× 182 0.7× 205 1.6× 138 1.4× 74 0.9× 20 907

Countries citing papers authored by J.R. Selden

Since Specialization
Citations

This map shows the geographic impact of J.R. Selden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.R. Selden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.R. Selden more than expected).

Fields of papers citing papers by J.R. Selden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.R. Selden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.R. Selden. The network helps show where J.R. Selden may publish in the future.

Co-authorship network of co-authors of J.R. Selden

This figure shows the co-authorship network connecting the top 25 collaborators of J.R. Selden. A scholar is included among the top collaborators of J.R. Selden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.R. Selden. J.R. Selden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bilello, John P., Massimiliano La Colla, Michel Liuzzi, et al.. (2009). 344 PRECLINICAL PROFILES OF IDX136 AND IDX316, TWO NOVEL MACROCYCLIC HCV PROTEASE INHIBITORS. Journal of Hepatology. 50. S132–S132. 1 indexed citations
2.
Standring, David N., Margareta Larsson, Claire Pierra, et al.. (2008). 67 POTENT ANTIVIRAL ACTIVITY OF SECOND GENERATION NUCLEOSIDE INHIBITORS, IDX102 AND IDX184, IN HCV-INFECTED CHIMPANZEES. Journal of Hepatology. 48. S30–S30. 16 indexed citations
3.
Bridges, Edward G., J.R. Selden, & Shouqi Luo. (2008). Nonclinical Safety Profile of Telbivudine, a Novel Potent Antiviral Agent for Treatment of Hepatitis B. Antimicrobial Agents and Chemotherapy. 52(7). 2521–2528. 23 indexed citations
4.
White, Gary W., et al.. (2007). Effect of Prophylactic Intramuscular Administration of Polysulfated Glycosaminoglycan on Developmental and Traumatic Joint Injuries in Thoroughbred Foals. Journal of Equine Veterinary Science. 27(3). 107–111. 2 indexed citations
5.
Selden, J.R. & Frank Dolbeare. (1994). Chapter 1 A Flow Cytometric Technique for Detection of DNA Repair in Mammalian Cells. Methods in cell biology. 42 Pt B. 1–19. 3 indexed citations
6.
Selden, J.R., et al.. (1994). Validation of a flow cytometric in vitro DNA repair (UDS) assay in rat hepatocytes. Mutation Research/DNA Repair. 315(2). 147–167. 28 indexed citations
7.
Dolbeare, Frank & J.R. Selden. (1994). Chapter 19 Immunochemical Quantitation of Bromodeoxyuridine: Application to Cell–Cycle Kinetics. Methods in cell biology. 41. 297–316. 53 indexed citations
9.
10.
Selden, J.R., Richard T. Robertson, Judith E. Miller, et al.. (1989). The Rapid and Sensitive Detection of Perturbations in Spermatogenesis: Assessment by Quantitative Dual Parameter (DNA/RNA) Flow Cytometry. Journal of the American College of Toxicology. 8(3). 507–523. 1 indexed citations
11.
Emanuel, Beverly S., et al.. (1984). In situ hybridization and translocation breakpoint mapping. Cytogenetic and Genome Research. 38(2). 127–131. 30 indexed citations
12.
Emanuel, B S, J.R. Selden, R. S. K. Chaganti, et al.. (1984). The 2p breakpoint of a 2;8 translocation in Burkitt lymphoma interrupts the V kappa locus.. Proceedings of the National Academy of Sciences. 81(8). 2444–2446. 43 indexed citations
13.
Selden, J.R., Paul S. Moorhead, G C Koo, et al.. (1984). Inherited XX sex reversal in the cocker spaniel dog. Human Genetics. 67(1). 62–69. 25 indexed citations
14.
Selden, J.R., B S Emanuel, Linda A. Cannizzaro, et al.. (1983). Amplified C lambda and c-abl genes are on the same marker chromosome in K562 leukemia cells.. Proceedings of the National Academy of Sciences. 80(23). 7289–7292. 76 indexed citations
15.
Nowell̀, Peter C., J Finan, Riccardo Dalla Favera, et al.. (1983). Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukaemia cell line. Nature. 306(5942). 494–497. 128 indexed citations
16.
Selden, J.R.. (1982). H-Y antigen and sex determination in animals.. PubMed. 94. 381–418. 1 indexed citations
17.
Haskins, Mark E., et al.. (1982). Persistent Müllerian duct syndrome in miniature schnauzers. Journal of the American Veterinary Medical Association. 181(8). 798–801. 19 indexed citations
18.
Selden, J.R., et al.. (1979). Breeding studies reveal segregation of a canine Robertsonian translocation along Mendelian proportions. Cytogenetic and Genome Research. 24(2). 95–101. 11 indexed citations
19.
Selden, J.R. & Stephen S. Wachtel. (1977). H-Y ANTIGEN IN THE DOG. Transplantation. 24(4). 298–298. 5 indexed citations
20.
Selden, J.R., et al.. (1975). The Giemsa banding pattern of the canine karyotype. Cytogenetic and Genome Research. 15(6). 380–387. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026